739 related articles for article (PubMed ID: 21528865)
21. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
22. Effects of Iron-Oxide Nanoparticle Surface Chemistry on Uptake Kinetics and Cytotoxicity in CHO-K1 Cells.
Hanot CC; Choi YS; Anani TB; Soundarrajan D; David AE
Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26729108
[TBL] [Abstract][Full Text] [Related]
23. Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging.
Sharifi S; Seyednejad H; Laurent S; Atyabi F; Saei AA; Mahmoudi M
Contrast Media Mol Imaging; 2015; 10(5):329-55. PubMed ID: 25882768
[TBL] [Abstract][Full Text] [Related]
24. Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications.
Jin R; Lin B; Li D; Ai H
Curr Opin Pharmacol; 2014 Oct; 18():18-27. PubMed ID: 25173782
[TBL] [Abstract][Full Text] [Related]
25. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
26. Magnetic core-shell hybrid nanoparticles for receptor targeted anti-cancer therapy and magnetic resonance imaging.
Shanavas A; Sasidharan S; Bahadur D; Srivastava R
J Colloid Interface Sci; 2017 Jan; 486():112-120. PubMed ID: 27697648
[TBL] [Abstract][Full Text] [Related]
27. Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo.
Lee H; Yu MK; Park S; Moon S; Min JJ; Jeong YY; Kang HW; Jon S
J Am Chem Soc; 2007 Oct; 129(42):12739-45. PubMed ID: 17892287
[TBL] [Abstract][Full Text] [Related]
28. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
[TBL] [Abstract][Full Text] [Related]
29. Superparamagnetic iron oxide nanoparticles (SPIONs): synthesis and surface modification techniques for use with MRI and other biomedical applications.
Yoffe S; Leshuk T; Everett P; Gu F
Curr Pharm Des; 2013; 19(3):493-509. PubMed ID: 22934920
[TBL] [Abstract][Full Text] [Related]
30. Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo.
Jalalian SH; Taghdisi SM; Shahidi Hamedani N; Kalat SA; Lavaee P; Zandkarimi M; Ghows N; Jaafari MR; Naghibi S; Danesh NM; Ramezani M; Abnous K
Eur J Pharm Sci; 2013 Oct; 50(2):191-7. PubMed ID: 23835028
[TBL] [Abstract][Full Text] [Related]
31. Nonpolymeric surface-coated iron oxide nanoparticles for in vivo molecular imaging: biodegradation, biocompatibility, and multiplatform.
Lee CM; Cheong SJ; Kim EM; Lim ST; Jeong YY; Sohn MH; Jeong HJ
J Nucl Med; 2013 Nov; 54(11):1974-80. PubMed ID: 24050935
[TBL] [Abstract][Full Text] [Related]
32. Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics.
Mok H; Zhang M
Expert Opin Drug Deliv; 2013 Jan; 10(1):73-87. PubMed ID: 23199200
[TBL] [Abstract][Full Text] [Related]
33. Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging.
Chiang WH; Huang WC; Chang CW; Shen MY; Shih ZF; Huang YF; Lin SC; Chiu HC
J Control Release; 2013 Jun; 168(3):280-8. PubMed ID: 23562635
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and characterization of dextran stabilized superparamagnetic iron oxide nanoparticles for in vivo MR imaging of liver fibrosis.
Saraswathy A; Nazeer SS; Nimi N; Arumugam S; Shenoy SJ; Jayasree RS
Carbohydr Polym; 2014 Jan; 101():760-8. PubMed ID: 24299836
[TBL] [Abstract][Full Text] [Related]
35. Selective in vitro anticancer effect of superparamagnetic iron oxide nanoparticles loaded in hyaluronan polymeric micelles.
Smejkalová D; Nešporová K; Huerta-Angeles G; Syrovátka J; Jirák D; Gálisová A; Velebný V
Biomacromolecules; 2014 Nov; 15(11):4012-20. PubMed ID: 25268047
[TBL] [Abstract][Full Text] [Related]
36. Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion.
Rojas JM; Sanz-Ortega L; Mulens-Arias V; Gutiérrez L; Pérez-Yagüe S; Barber DF
Nanomedicine; 2016 May; 12(4):1127-1138. PubMed ID: 26733263
[TBL] [Abstract][Full Text] [Related]
37. Interactions of iron oxide nanoparticles with the immune system: challenges and opportunities for their use in nano-oncology.
Baiu DC; Brazel CS; Bao Y; Otto M
Curr Pharm Des; 2013; 19(37):6606-21. PubMed ID: 23621531
[TBL] [Abstract][Full Text] [Related]
38. Dye-doped biodegradable nanoparticle SiO
Navarro-Palomares E; González-Saiz P; Renero-Lecuna C; Martín-Rodríguez R; Aguado F; González-Alonso D; Fernández Barquín L; González J; Bañobre-López M; Fanarraga ML; Valiente R
Nanoscale; 2020 Mar; 12(10):6164-6175. PubMed ID: 32133463
[TBL] [Abstract][Full Text] [Related]
39. In vivo Biodistribution and Clearance of Magnetic Iron Oxide Nanoparticles for Medical Applications.
Nowak-Jary J; Machnicka B
Int J Nanomedicine; 2023; 18():4067-4100. PubMed ID: 37525695
[TBL] [Abstract][Full Text] [Related]
40. Differential effect of polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles on BT-474 human breast cancer cell viability.
Aliakbari M; Mohammadian E; Esmaeili A; Pahlevanneshan Z
Toxicol In Vitro; 2019 Feb; 54():114-122. PubMed ID: 30266435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
